Evidence map›Paper›PMID 41699977›Full record

ArticleACS synthetic biology2026

Impact of Reducing Agents on Protein Synthesis in a Reconstituted Cell-Free Protein Synthesis System.

Tomoe Fuse-Murakami, Shohei Terazawa, Riddhi Gondhalekar, Shohei Ito, Seiichi Miyawaki, Yusuke Mizukami, Willian P Salgado, Zening Yang, Kosuke Fujishima, Takashi Kanamori

Abstract read
In one paragraph

Article in ACS synthetic biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Tomoe Fuse-MurakamiGeneFrontier Corporation, 273-1 Kashiwa, Kashiwa, Chiba 277-0005, Japan.
Shohei TerazawaSchool of Life Science and Technology, Institute of Science Tokyo, Tokyo 152-8550, Japan.
Riddhi GondhalekarSchool of Life Science and Technology, Institute of Science Tokyo, Tokyo 152-8550, Japan.
Shohei ItoSchool of Life Science and Technology, Institute of Science Tokyo, Tokyo 152-8550, Japan.
Seiichi MiyawakiSchool of Science, Institute of Science Tokyo, Tokyo 152-8550, Japan.
Yusuke MizukamiSchool of Science, Institute of Science Tokyo, Tokyo 152-8550, Japan.
Willian P SalgadoSchool of Science, Institute of Science Tokyo, Tokyo 152-8550, Japan.
Zening YangSchool of Materials and Chemical Technology, Institute of Science Tokyo, Tokyo 152-8550, Japan.
Kosuke FujishimaEarth-Life Science Institute (ELSI), Institute of Science Tokyo, Tokyo 152-8550, Japan.ORCID 0000-0002-8844-812X
Takashi KanamoriGeneFrontier Corporation, 273-1 Kashiwa, Kashiwa, Chiba 277-0005, Japan.ORCID 0000-0001-9150-5968

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Maintaining proper redox conditions is essential for protein stability and function. In cell-free protein synthesis, reducing agents, such as dithiothreitol and reduced glutathione, are commonly added to mimic the cytosolic environment and prevent unwanted oxidation. The PURE system, which is a fully reconstituted protein synthesis system, also contains reducing agents. Here, we systematically examined how reducing agents affect the protein synthesis in the PURE system. We found that the reducing activity of dithiothreitol decreased during prolonged reactions, leading to the formation of disulfide bonds in synthesized proteins. Dissolved oxygen and contaminating metal ions were identified as major factors causing this loss of activity. Based on these findings, we developed a method to maintain reducing conditions throughout the reaction, ensuring consistent protein quality. Our results provide new insights into redox regulation in cell-free systems and offer a practical strategy for the efficient synthesis of functional proteins, with potential applications in biotechnology and therapeutic protein production.

Indexed as

Protein BiosynthesisReducing AgentsCell-Free SystemDisulfidesDithiothreitolGlutathioneOxidation-ReductionDisulfidesDithiothreitolGlutathioneReducing Agentscell-free protein synthesischelatorPURE systemreducing agent

Identifiers

PMID41699977
PMCPMC13010799

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.